The present study was to develop a simple, accurate, rapid and precise isocratic stability indicating RP-high-performance liquid chromatographic method for simultaneous estimation of Doxofylline and Sertraline in tablet dosage form. The separation method was carried out using shimadzu-HPLC with empower software, UV detector and with BDS column (250mm x 4.6 mm, 5µ), an injection volume of 10μl is injected and eluted with the mobile phase of mixed buffer (0.01N sodium dihydrogen ortho phosphate): acetonitrile (30: 70), which was pumped at a flow rate of 1.1ml/min and detected by UV detector at 220nm. The peaks of Doxofylline and Sertraline were found well separated at 2.4 and 3.7 respectively. Assay studies, it was found that the formulation contains 99.93% of Doxofylline and 99.931% of Sertraline. System suitability studies, it was found that all the system suitability parameters were within the acceptance criteria. Linearity, it was found that the drug obeys linearity within the concentration range of 50 -300g/ml for Doxofylline, 6.25-37.5g/ml for Sertraline. Accuracy, it was found that the percentage recovery values of pure drug from the pre-analysed solutions of formulations were in between 99.4% for Doxofylline, 99.5% for Sertraline, which indicates that the method was accurate. Precision, it was found that % RSD is less than 2%; which indicates that the proposed method has good reproducibility. Robustness, it was found that there is little change in the results with the change in the parameters like flow rate and temperature, indicating the robustness of the method. The developed chromatographic method for the determination of Doxofylline and Sertraline in tablet dosage forms was simple, rapid, accurate, precise, specific, robust and economical.
INTRODUCTION
For the treatment of asthma xanthine derivative Doxofylline was used. It is a phosphodiesterase inhibitor, and having bronchodilator, antitussive effects, Chemically, Doxofylline is 7-(1,3-dioxolan-2-methyl)-1,3-dimethyl purine-2,6-dione. Sertraline is a selective serotonin reuptake inhibitor, to treat panic, social anxiety disorder of both adults and children's Chemically, Sertraline is (1S, 4S)-4-(3, 4-dichlorophenyl)-Nmethyl -1, 2, 3, 4 tetrahydronaphthalen-1-amine. [1] [2] [3] [4] [5] [6] [7] [8] The literature survey reveals that there is no reported method on simultaneous estimation of Doxofylline and Sertraline in combined tablet dosage forms. Hence, it is necessary to develop a rapid, accurate and validated RP-HPLC method for the determination of Doxofylline and Sertraline from combined dosage form [10] [11] [12] [13] [14] . The method followed according to ICH guidelines.
MATERIALS &METHODS
Acetonitrile and water of HPLC grade were procured from Sigma-Aldrich, Doxofylline and Sertraline standards were received as gift samples from Glochem Laboratories, Hyderabad, India. O-phosphoric acid was purchased from E. Merck chemicals, Mumbai, India. Tablet DOXODER having combination of Sertraline (50mg), Doxofylline (400mg) was used.
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Analytical Method Development
Development and optimization of liquid chromatography is interesting in research field. Among all, the liquid chromatographic methods, the RP systems based on modified silica offers the best results. However, many (system) variables (parameters) affect the selectivity and the resolution. [15] [16] [17] [18] 
RESULTS AND DISCUSSIONS

System suitability
All the system parameters are within range and satisfactory according to ICH guidelines.
Linearity:
The linearity of analyte is its ability to obtain test results, which are directly proportional to the concentration (amount) of analyte in the sample.
Precision: Intraday precision (Repeatability):
Acceptance Criteria: The % RSD for the area of 5 standard injections results should be ≤2%. Result: The percentage relative standard deviation for the peak area of Doxofylline and Sertraline was 0.7 and 0.4 at the working concentrations. The result complies with the acceptance criteria and indicates acceptable precision of the system.
Assay:
From formulation samples was prepared and from Active pharmaceutical ingredient standard solution was prepared. Both sample and standards are injected 5 samples. The Average %Assay was calculated and found to be 99.93% and 99.931% for Doxofylline and sertraline respectively.
Accuracy
Acceptance criteria: The percentage recovery should be in the range of 99.0 to 101.0 and the percentage relative standard deviation should not be more than 2.00. Detection Limit: The detection limit of an individual analytical procedure is the lowest amount of analyte in a sample, which can be detected but not necessarily quantities under stated experimental conditions.
Calculation:
Spl area Std. Dil. Fac Avg. Wt of Tab Assay = -----------X ----------------X ------------------X
LOD=3.3*standard deviation of Intercept/Average of Slope
Result: Limit of detection was calculated by intercept method and LOD for Doxofylline and Sertraline were found to be 0.1µg/ml and 0.1µg/ml respectively.
LOQ: Quantization Limit:
The quantization limit of an individual analytical procedure is defined as the lowest amount of analyte in a sample, which can be quantitatively determined with suitable precision and accuracy LOQ=10*standard deviation of Intercept/Average of Slope Result: limit of Quantification was calculated by intercept method and LOQ for Doxofylline and Sertraline were found to be 0.3µg/ml and 0.3 µg/ml respectively.
Robustness:
Small deliberate changes in method like Flow rate, mobile phase ratio, and temperature are made but there were no recognized change in the result and are within range as per ICH Guide lines.
Acceptance Criteria: RSD < 2%. Robustness conditions like Flow minus (0.9ml/min), Flow plus (1.1ml/min), mobile phase minus, mobile phase plus, temperature minus (25°C) and temperature plus (35°C) was maintained and samples were injected in duplicate manner. System suitability parameters were not much affected and all the parameters were passed. %RSD was within the limit. 
SUMMARY
An attempt has been made to develop the RP-HPLC method for simultaneous estimation of Doxofylline and Sertraline in combined dosage form. As the literature survey revealed that few methods were available for their estimation individually, but there is a need of a simple, economical and proper method for estimation of above combination in combined dosage form.
CONCLUSION
The present study was validated as per the ICH guidelines. From the comparative study, it was inferred that the method is simple, specific, precise, linear, sensitive, and system suitability. The results obtained on the validation parameter met the respective acceptance criteria. 
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